Package 67172-937-04

{"route": ["ORAL"], "spl_id": "522529b5-13c6-432f-95aa-c49136124f50", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "upc": ["0678112000685"], "unii": ["PDC6A3C0OX", "339NCG44TV"], "rxcui": ["1101852", "1101854"], "spl_set_id": ["882c940c-b3c3-4aa4-8d64-e4260f066ff4"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Prestige Brands Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, DISPENSING in 1 BOX (67172-937-04)  / 118 mL in 1 BOTTLE, DISPENSING", "package_ndc": "67172-937-04", "marketing_start_date": "20210601"}], "brand_name": "Chloraseptic Sore Throat Max", "product_id": "67172-937_522529b5-13c6-432f-95aa-c49136124f50", "dosage_form": "SPRAY", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Non-Standardized Chemical Allergen [EPC]"], "product_ndc": "67172-937", "generic_name": "Phenol and Glycerin", "labeler_name": "Prestige Brands Holdings, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Chloraseptic Sore Throat Max", "active_ingredients": [{"name": "GLYCERIN", "strength": "330 mg/mL"}, {"name": "PHENOL", "strength": "15 mg/mL"}], "application_number": "M022", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20110201", "listing_expiration_date": "20261231"}